These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18781994)

  • 1. Candidate circulating biomarkers for the cardiovascular disease continuum.
    Dotsenko O; Chackathayil J; Patel JV; Gill PS; Lip GY
    Curr Pharm Des; 2008; 14(24):2445-61. PubMed ID: 18781994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Biomarkers for Predicting Cardiovascular Disease in Patients With Diabetes.
    Retnakaran R
    Can J Cardiol; 2018 May; 34(5):624-631. PubMed ID: 29287943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review on cardiovascular risk prediction.
    Ruwanpathirana T; Owen A; Reid CM
    Cardiovasc Ther; 2015 Apr; 33(2):62-70. PubMed ID: 25758853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating biomarkers.
    Badimon L; Romero JC; Cubedo J; Borrell-Pagès M
    Thromb Res; 2012 Oct; 130 Suppl 1():S12-5. PubMed ID: 23026650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases.
    Battistoni A; Rubattu S; Volpe M
    Int J Cardiol; 2012 May; 157(2):160-8. PubMed ID: 21763018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
    Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
    Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
    Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
    Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Exosomes in Cardiovascular Diseases.
    Bei Y; Chen T; Banciu DD; Cretoiu D; Xiao J
    Adv Exp Med Biol; 2017; 998():255-269. PubMed ID: 28936745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for cardiovascular disease: challenges and future directions.
    May A; Wang TJ
    Trends Mol Med; 2008 Jun; 14(6):261-7. PubMed ID: 18487087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-1 levels and cardiovascular events.
    Jankowich M; Choudhary G
    Trends Cardiovasc Med; 2020 Jan; 30(1):1-8. PubMed ID: 30765295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac biomarkers in diabetes mellitus: New dawn for risk stratification?
    Berezin AE
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S201-S208. PubMed ID: 28011232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating C-type natriuretic peptide and its relationship to cardiovascular disease in the general population.
    Sangaralingham SJ; McKie PM; Ichiki T; Scott CG; Heublein DM; Chen HH; Bailey KR; Redfield MM; Rodeheffer RJ; Burnett JC
    Hypertension; 2015 Jun; 65(6):1187-94. PubMed ID: 25895587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microparticles in cardiovascular disease: going on stage!
    Fernández M; Calligaris SD
    Biomarkers; 2019 Jul; 24(5):423-428. PubMed ID: 31068021
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel Risk Markers and Risk Assessments for Cardiovascular Disease.
    Thomas MR; Lip GY
    Circ Res; 2017 Jan; 120(1):133-149. PubMed ID: 28057790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging noninvasive biochemical measures to predict cardiovascular risk.
    Pahor M; Elam MB; Garrison RJ; Kritchevsky SB; Applegate WB
    Arch Intern Med; 1999 Feb; 159(3):237-45. PubMed ID: 9989535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying new Risk Markers and Potential Targets: The Value of the Proteome.
    Kontush A
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):13-8. PubMed ID: 26931819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients.
    Tsimikas S; Willerson JT; Ridker PM
    J Am Coll Cardiol; 2006 Apr; 47(8 Suppl):C19-31. PubMed ID: 16631506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Plasma Testosterone Is Associated With Elevated Cardiovascular Disease Biomarkers.
    Pastuszak AW; Kohn TP; Estis J; Lipshultz LI
    J Sex Med; 2017 Sep; 14(9):1095-1103. PubMed ID: 28757119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary prevention.
    Leistner DM; Klotsche J; Pieper L; Stalla GK; Lehnert H; Silber S; März W; Wittchen HU; Zeiher AM;
    Clin Chem; 2012 Jan; 58(1):200-8. PubMed ID: 22156668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.